SCHEMBL13702372

SCHEMBL13702372

CCNC(=O)c1cccc(C(=O)N(C)Cc2ccccc2)c1

nearest known ligand 0.76

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.76
▸ MEN1 O00255 2/20 0.76
▸ ALDH1A1 P00352 2/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ HDAC1 Q13547 1/20 0.56
▸ HDAC6 Q9UBN7 1/20 0.56
▸ SIRT2 Q8IXJ6 1/20 0.53
▸ MAPT P10636 1/20 0.52
▸ TMEM97 Q5BJF2 1/20 0.52
▸ SIGMAR1 Q99720 1/20 0.52
▸ HPGD P15428 2/20 0.51
▸ GAA P10253 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ AOC3 Q16853 2/20 0.51
▸ HSP90AA1 P07900 1/20 0.51
▸ HTT P42858 1/20 0.50
▸ TP53 P04637 1/20 0.50
▸ HSD17B1 P14061 1/20 0.50
▸ HSD17B2 P37059 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13229125 0.83 KMT2A (0.90) KMT2AMEN1ALDH1A1SMN1; SMN2HDAC1
SCHEMBL13701737 0.83 KMT2A (0.74) KMT2AMEN1ALDH1A1SMN1; SMN2HDAC1
SCHEMBL1696458 0.82 KMT2A (0.77) KMT2AMEN1ALDH1A1SMN1; SMN2HDAC1
SCHEMBL15676710 0.81 KMT2A (0.82) KMT2AMEN1ALDH1A1SMN1; SMN2HDAC1
SCHEMBL13702339 0.81 SMN1; SMN2 (0.54) KMT2AMEN1ALDH1A1SMN1; SMN2HDAC6
SCHEMBL13229122 0.81 KMT2A (0.80) KMT2AMEN1ALDH1A1SMN1; SMN2HDAC1
SCHEMBL13702290 0.80 HDAC6 (0.74) KMT2AALDH1A1SMN1; SMN2HDAC1HDAC6
SCHEMBL1003665 0.79 KMT2A (0.83) KMT2AMEN1ALDH1A1HDAC1HDAC6
SCHEMBL9713054 0.79 SMN1; SMN2 (0.67) KMT2AMEN1ALDH1A1SMN1; SMN2HDAC1
SCHEMBL18186542 0.79 KMT2A (0.82) KMT2AMEN1ALDH1A1SMN1; SMN2SIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227588-A1 Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors FLECK ROMAN WOLFGANG 2009-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227588-A1 Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors EPHX1, EPHX2, EPX KMT2A 3792/4885MEN1 4409/4885ALDH1A1 376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback